Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study
Clinical trial NCT02933879 · COMPLETED
Trial details
- NCT number
- NCT02933879
- Sponsor
- Sun Pharmaceutical Industries, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-21
- Primary completion
- 2018-03-06
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.